Express Scripts Wants Class Bid Cut In Acthar Case

By Celeste Bott · November 14, 2023, 7:58 PM EST

Express Scripts and its subsidiaries asked an Illinois federal judge Monday not to certify a class of customers bringing antitrust allegations over sales of the anti-seizure drug Acthar, saying it doesn't...

To view the full article, register now.